Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's What Happened

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $12.14, but opened at $11.85. Sionna Therapeutics shares last traded at $12.31, with a volume of 562 shares traded.

Analyst Ratings Changes

SION has been the subject of a number of research reports. Stifel Nicolaus initiated coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a "buy" rating and a $32.00 price objective for the company. TD Cowen began coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a "buy" rating for the company. Finally, Guggenheim assumed coverage on shares of Sionna Therapeutics in a report on Tuesday, March 4th. They issued a "buy" rating and a $45.00 price target on the stock.

Sionna Therapeutics Trading Up 5.3 %

The company's 50 day simple moving average is $12.45.

Sionna Therapeutics (NASDAQ:SION - Get Free Report) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($3.38) earnings per share for the quarter, missing the consensus estimate of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.